231 related articles for article (PubMed ID: 22972687)
1. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.
Friedrich P; Ortiz R; Strait K; Fuentes S; Gamboa Y; Arambú I; Ah-Chu-Sanchez M; London W; Rodríguez-Galindo C; Antillón-Klussmann F; Báez F;
Cancer; 2013 Feb; 119(4):871-9. PubMed ID: 22972687
[TBL] [Abstract][Full Text] [Related]
2. Barriers to effective treatment of pediatric solid tumors in middle-income countries: can we make sense of the spectrum of nonbiologic factors that influence outcomes?
Friedrich P; Ortiz R; Fuentes S; Gamboa Y; Ah Chu-Sanchez MS; Arambú IC; Montero M; Báez F; Rodríguez-Galindo C; Antillón-Klussmann F;
Cancer; 2014 Jan; 120(1):112-25. PubMed ID: 24132910
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Devadas SK; Banavali S
Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
[TBL] [Abstract][Full Text] [Related]
4. Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 Decades.
Chen I; Pasalic D; Fischer-Valuck B; Frangoul H; DeWees T; Shinohara ET; Perkins SM
Am J Clin Oncol; 2018 May; 41(5):471-475. PubMed ID: 27841802
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary treatment for childhood sarcoma.
Jaffe N; Murray J; Traggis D; Cassady RJ; Filler RM; Watts H; Weichselbaum R; Weinstein H
Am J Surg; 1977 Apr; 133(4):405-13. PubMed ID: 300570
[TBL] [Abstract][Full Text] [Related]
6. Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial.
Frank JA; Ranft A; Paulussen M; Juergens H; Kruseova J; Bauer S; Niggli F; Reichardt P; Dirksen U
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436593
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas.
Vasquez L; León E; Beltran B; Maza I; Oscanoa M; Geronimo J
J Pediatr Hematol Oncol; 2017 Oct; 39(7):538-546. PubMed ID: 28697168
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes of infantile soft-tissue sarcoma: A multicenter retrospective study in Beijing.
Zhu S; Xu N; Zhi T; Gao Y; Zhong D; Zhang W; Jin M; Sun Q; Xie Y; Zhang X; Li L; Wang S; Wang H; Liu R; Zhao W; Huang D; Ni X; Ma X
J Cancer Res Ther; 2023 Aug; 19(4):876-880. PubMed ID: 37675711
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience.
Parasuraman S; Langston J; Rao BN; Poquette CA; Jenkins JJ; Merchant T; Cain A; Pratt CB; Pappo AS
J Pediatr Hematol Oncol; 1999; 21(5):370-7. PubMed ID: 10524449
[TBL] [Abstract][Full Text] [Related]
10. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma.
Dickens DS; Kozielski R; Leavey PJ; Timmons C; Cripe TP
J Pediatr Hematol Oncol; 2003 Apr; 25(4):282-5. PubMed ID: 12679640
[TBL] [Abstract][Full Text] [Related]
12. A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study.
Pappo AS; Vassal G; Crowley JJ; Bolejack V; Hogendoorn PC; Chugh R; Ladanyi M; Grippo JF; Dall G; Staddon AP; Chawla SP; Maki RG; Araujo DM; Geoerger B; Ganjoo K; Marina N; Blay JY; Schuetze SM; Chow WA; Helman LJ
Cancer; 2014 Aug; 120(16):2448-56. PubMed ID: 24797726
[TBL] [Abstract][Full Text] [Related]
13. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.
Stiller CA; Passmore SJ; Kroll ME; Brownbill PA; Wallis JC; Craft AW
Br J Cancer; 2006 Jan; 94(1):22-9. PubMed ID: 16317433
[TBL] [Abstract][Full Text] [Related]
15. Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study.
Modritz D; Ladenstein R; Pötschger U; Amman G; Dieckmann K; Horcher E; Urban C; Meister B; Schmitt K; Jones R; Kaulfersch W; Haas H; Moser R; Stöllinger O; Peham M; Gadner H; Koscielniak E; Treuner J
Wien Klin Wochenschr; 2005 Mar; 117(5-6):196-209. PubMed ID: 15875759
[TBL] [Abstract][Full Text] [Related]
16. Conditional survival of pediatric, adolescent, and young adult soft tissue sarcoma and bone tumor patients.
Ou JY; Spraker-Perlman H; Dietz AC; Smits-Seemann RR; Kaul S; Kirchhoff AC
Cancer Epidemiol; 2017 Oct; 50(Pt A):150-157. PubMed ID: 28992567
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
[TBL] [Abstract][Full Text] [Related]
18. An evolutionary framework for treating pediatric sarcomas.
Reed DR; Metts J; Pressley M; Fridley BL; Hayashi M; Isakoff MS; Loeb DM; Makanji R; Roberts RD; Trucco M; Wagner LM; Alexandrow MG; Gatenby RA; Brown JS
Cancer; 2020 Jun; 126(11):2577-2587. PubMed ID: 32176331
[TBL] [Abstract][Full Text] [Related]
19. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
